Brief: ISR H2 Operating Loss Widens To SEK 13.1 Million
Feb 26 (Reuters) - ISR Immune System Regulation Holding AB
(publ) ISR.ST :
* H2 OPERATING LOSS SEK 13.1 MILLION VERSUS LOSS SEK 12.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrF9WHK
Further company coverage: ISR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on ISR Immune System Regulation Holding AB (publ)
See all newsBrief: ISR Holding Shares To Be Delisted From Nasdaq First North Growth Market
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent